TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 57 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 1,200,000 | $249,000 | 0.15% |
| SABBY MANAGEMENT, LLC | 1,518,294 | $314,000 | 0.04% |
| Cornerstone Wealth Management, LLC | 2,400 | $1,000,000 | 0.01% |
| ARMISTICE CAPITAL, LLC | 220,000 | $46,000 | 0.00% |
| Ballew Advisors, Inc | 4,000 | $1,000 | 0.00% |
| Blume Capital Management, Inc. | 2,546 | $1,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 10,000 | $2,000 | 0.00% |
| UBS Group AG | 5,316 | $1,000 | 0.00% |
| Stratos Wealth Partners, LTD. | 1,500 | $0 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 2,820 | $0 | 0.00% |